Upon the chemotherapeutic irinotecan treatment, PXR/SXR is translocated into the nucleus, binds to RXR, and the heterodimer interacts with the promoter of the CYP3A4 gene to induce its expression in colon cancer cell lines. Here, NR1I2 is linked to malignant colon neoplasm.